Stay updated on Pembrolizumab vs Standard Therapy in MSI-H/dMMR Stage IV CRC Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab vs Standard Therapy in MSI-H/dMMR Stage IV CRC Clinical Trial page.

Latest updates to the Pembrolizumab vs Standard Therapy in MSI-H/dMMR Stage IV CRC Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedThe record history shows a new revision entry v3.3.2 and the older revision v3.3.1 is removed from the listing.SummaryDifference0.0%

- Check21 days agoChange DetectedA new entry Revision: v3.3.1 was added to the history, and the entry Revision: v3.2.0 was removed.SummaryDifference0.0%

- Check29 days agoChange DetectedThe government funding/operating status notice was removed from the page. This removes guidance about data freshness and NIH operating status.SummaryDifference0.3%

- Check43 days agoChange DetectedA new version entry dated 2024-09-18 was added to the study record history, increasing the number of listed versions. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check72 days agoChange DetectedMajor update: page now includes a government funding status notice and indicates version 3.2.0, replacing the previous 3.1.0.SummaryDifference8%

- Check79 days agoChange DetectedPage revision updated from v3.0.2 to v3.1.0, indicating a version bump with no other substantive content changes.SummaryDifference0.2%

Stay in the know with updates to Pembrolizumab vs Standard Therapy in MSI-H/dMMR Stage IV CRC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab vs Standard Therapy in MSI-H/dMMR Stage IV CRC Clinical Trial page.